Attention: Restrictions on use of AUA, AUAER, and UCF content in third party applications, including artificial intelligence technologies, such as large language models and generative AI.
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.

From the AUA Science and Quality Council: AUA Guidelines Update

By: David Penson, MD, MPH | Posted on: 01 May 2021

The COVID-19 pandemic affected organizations around the world, and the American Urological Association (AUA) is no exception. Despite a number of challenges, 2020 was still a strong year for content development and distribution. Following cancellation of the 2020 Annual Meeting, AUA implemented a robust online program that featured an array of content aimed at connecting with and educating the urologic community. More so than ever, members showed ongoing support of the Guidelines program in upholding the AUA mission to promote the highest standards of urologic care through evidence-based medicine.

Following a transition to a completely virtual development and dissemination process, 2020 saw the release of four new guidelines on Advanced Prostate Cancer, Microhematuria, Disorders of Ejaculation and Male Infertility. Additionally, amendments were released on Urotrauma, Surgical Management of Benign Prostatic Hyperplasia (BPH), Non-Muscle Invasive Bladder Cancer and Muscle-Invasive Bladder Cancer. The Guidelines program also continued development on a number of additional topics, with guidelines on Medical Management of BPH, Priapism and Neurogenic Lower Urinary Tract Dysfunction all anticipated for release ahead of the 2021 AUA Annual Meeting. Further guidelines on Localized and Locally Advanced Prostate Cancer, Early Detection of Prostate Cancer and Upper Tract Urothelial Carcinoma will continue in development into 2022. These topics will be featured prominently in future venues, include Annual Meeting and year-round educational courses.

Looking forward, the Guidelines program will continue in its efforts to connect with the AUA membership and provide additional opportunities to allow for members to contribute directly to the program. As additional topics are evaluated for guideline development, members are invited to nominate future topics for consideration by visiting www.auanet.org/guidelines/topic-submission. Members are encouraged to submit detailed nominations highlighting important guideline-based metrics, including literature quality, importance of the topic to urology and evidence of variation in patient care. In addition, the AUA is expanding its efforts to create diverse panels of subject matter experts representative of the entire urologic community. To this end, members are invited to visit the Guidelines website at www.auanet.org/guidelines for updates on available engagement opportunities. Further, AUA continues to welcome experts from outside specialties as well as patients and patient advocates to serve on panels and review guidelines to ensure inclusion of the diverse perspectives of both the multidisciplinary team members providing care as well as those patients undergoing treatment for increasingly complicated urologic conditions.

Members are reminded that all full-text guidelines may be accessed through the AUA website. In addition to executive summaries published in the Journal of Urology, Guidelines content is also available through the AUA Guidelines-at-a-Glance smartphone application. This user-friendly format is available for download from both the Apple and Android App Stores. Moving forward, AUA will continue to assess its Guidelines program to ensure all practices are in keeping with the highest standards of guideline development to ensure production of the quality, evidence-based documents that AUA members can trust.